University of Adelaide

Janet is using her research in clinical pharmacology and pharmacogenomics to develop our knowledge to enable the use of genetic testing for identifying patients at higher risk for drug toxicity &/or poor therapeutic outcomes.

Her research has been within various fields of clinical pharmacology including breast cancer, opioid dependence, cardiology and solid-organ transplantation. Importantly, the outcomes have been shown to be applicable within these patient groups.

Janet’s research has the potential to improve health outcomes for a wide variety of patients and enable personalised drug therapy to become a reality.